Variables | Group I (n = 10) | Group II (n = 14) | Group III (n = 6) | p | p (post-hoc analysis) |
---|---|---|---|---|---|
Albumin levels (g/dl) | 3.7 ± 0.2 | 3.2 ± 0.1 | 2.6 ± 0.4 |  |  |
Duration of disease (months) | 48 ± 50 | 45 ± 34 | 12 ± 3 | 0.530 | ns |
Age (years) | 56 ± 17 | 63 ± 12 | 76 ± 11 | 0.067 | ns |
BMI (kg/m2) | 18 ± 3 | 21 ± 3 | 20 ± 4 | 0.173 | ns |
Triceps skinfold (cm) | 1.2 ± 0.3 | 1.3 ± 0.3 | 0.9 ± 0.2 | 0.084 | ns |
Mid arm circumference (cm) | 23 ± 2 | 24 ± 2 | 22 ± 2 | 0.179 | ns |
Mid-arm muscle circumference (cm) | 19 ± 1 | 20 ± 2 | 19 ± 1 | 0.601 | ns |
PA (°) | 3.1 ± 0.5 | 2.7 ± 0.5 | 2.7 ± 1.2 | 0.306 | ns |
TBW (%) | 54 ± 6 | 54 ± 8 | 59 ± 12 | 0.569 | ns |
ECW (%) | 64 ± 5 | 68 ± 5 | 69 ± 11 | 0.211 | ns |
ICW (%) | 35 ± 5 | 31 ± 5 | 30 ± 11 | 0.204 | ns |
FFM (%) | 70 ± 9 | 71 ± 11 | 75 ± 15 | 0.746 | ns |
FM (%) | 29 ± 9 | 28 ± 11 | 24 ± 15 | 0.746 | ns |
RMR (kcal) | 1092 ± 61 | 1088 ± 73 | 1060 ± 103 | 0.753 | ns |
Energy expenditure (kcal) | 1263 ± 170 | 1255 ± 170 | 1088 ± 97 | 0.176 | ns |
Calories intake (kcal) | 1597 ± 240 | 1691 ± 297 | 1883 ± 404 | 0.279 | ns |
Glucose (mg/dl) | 91 ± 34 | 96 ± 22 | 101 ± 19 | 0.830 | ns |
Creatinine (mg/dl) | 0.68 ± 0.18 | 0.73 ± 0.18 | 0.73 ± 0.45 | 0.895 | ns |
Calcium (mg/dl) | 9.3 ± 0.5 | 8.9 ± 0.6 | 8.8 ± 0.2 | 0.243 | ns |
Hemoglobin (g/dl) | 13.8 ± 1.6 | 12.3 ± 1.6 | 9.7 ± 1.2 | 0.001 | I vs III 0.001 II vs III 0.025 |
Iron (mcg/dl) | 60 ± 26 | 45 ± 16 | 28 ± 9 | 0.064 | ns |
Transferrin (mg/dl) | 216 ± 14 | 191 ± 52 | 144 ± 16 | 0.207 | ns |
Prealbumin (mg/dl) | 16 ± 1 | 20 ± 2 | 16 ± 12 | 0.338 | ns |